Gene Sequencing tests in Dubai & UAE

Compare available Gene Sequencing tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

143

Listed price range

2,600.00–3,200.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Gene Sequencing test prices

Showing 91–105 of 143 matching tests.

Gene Sequencing diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-6372 PFKM Gene Glycogen Storage Disease Type VII (Tarui Disease) Genetic Test This test identifies pathogenic variants in the PFKM gene associated with Glycogen Storage Disease Type VII (Tarui disease). It confirms the molecular basis for symptoms like exerc...	Peripheral Whole Blood or Extracted DNA	21–28 Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PFKM gene", "Glycogenolytic pathway defects"] Parameters [] Preparation ["No specific fasting required", "Inform lab of recent blood transfusions (within 4 weeks)", "Avoid testing during acute metabolic crisis"] Indications ["Suspected Glycogen Storage Disease Type VII (Tarui disease)", "Differential diagnosis of metabolic myopathies", "Confirmation of clinical diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 92822-6 ICD-10: E74.09 Clinical summary This test identifies pathogenic variants in the PFKM gene associated with Glycogen Storage Disease Type VII (Tarui disease). It confirms the molecular basis for symptoms like exercise intolerance and rhabdomyolysis.
TEST-5567 PGK1 Gene Phosphoglycerate Kinase 1 Deficiency Genetic Test This test evaluates the PGK1 gene for pathogenic variants associated with phosphoglycerate kinase 1 deficiency.	Peripheral Whole Blood or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PGK1 gene", "Coding region and splice site variants", "Copy-number variants"] Parameters [] Preparation [] Indications ["Individuals presenting with unexplained hemolytic anemia, chronic myopathy, or movement disorders.", "Family history consistent with X-linked PGK1 deficiency.", "Carrier detection in at-risk female relatives.", "Reproductive planning when a familial variant is known."] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: E74.0 Clinical summary This test evaluates the PGK1 gene for pathogenic variants associated with phosphoglycerate kinase 1 deficiency.
TEST-5924 PHKA1 Gene Muscle Glycogenosis Genetic Test This genetic test evaluates the PHKA1 gene for pathogenic variants associated with muscle glycogenosis (glycogen storage disease type IXa). It identifies mutations causing this spe...	Whole blood, extracted DNA, or FTA card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PHKA1 gene", "Single nucleotide variants", "Small insertions/deletions", "Copy number alterations"] Parameters [] Preparation ["No specific fasting required.", "Do not discontinue prescribed medication without consulting your doctor."] Indications ["Individuals with unexplained muscle cramps, exercise intolerance, or recurrent myoglobinuria.", "Patients with a family history of glycogen storage disease or unexplained metabolic myopathy.", "Asymptomatic siblings for carrier risk assessment and reproductive planning.", "Athletes with recurrent rhabdomyolysis pursuing personalised training regimens."] Measurement technique Confirm with laboratory Codes LOINC: 94830-8 ICD-10: E74.09 Clinical summary This genetic test evaluates the PHKA1 gene for pathogenic variants associated with muscle glycogenosis (glycogen storage disease type IXa). It identifies mutations causing this specific metabolic myopathy.
TEST-4246 PIGA Gene Early Infantile Epileptic Encephalopathy Type 20 Genetic Test This genetic test identifies pathogenic variants in the PIGA gene associated with Early Infantile Epileptic Encephalopathy Type 20 (EIEE20).	Peripheral Whole Blood, Extracted DNA, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PIGA gene"] Parameters [] Preparation ["Provide clinical history"] Indications ["Suspected EIEE20", "Infantile epileptic encephalopathy", "Family history of EIEE20"] Measurement technique Confirm with laboratory Codes LOINC: 81409-8 ICD-10: G40.4 Clinical summary This genetic test identifies pathogenic variants in the PIGA gene associated with Early Infantile Epileptic Encephalopathy Type 20 (EIEE20).
TEST-5228 PIGT Gene Multiple Congenital Anomalies-Hypotonia-Seizures Syndrome Type 3 Genetic Test This test evaluates the PIGT gene for pathogenic variants associated with Multiple Congenital Anomalies–Hypotonia–Seizures Syndrome Type 3 (MCAHS3). It identifies specific genetic...	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PIGT gene", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (Indels)", "Copy Number Variants (CNVs)"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any current medications"] Indications ["Suspected diagnosis of Multiple Congenital Anomalies–Hypotonia–Seizures Syndrome Type 3 (MCAHS3)", "Family history of MCAHS3", "Need for genetic counseling regarding recurrence risk"] Measurement technique Confirm with laboratory Codes LOINC: 94222-7 ICD-10: Q87.8 Clinical summary This test evaluates the PIGT gene for pathogenic variants associated with Multiple Congenital Anomalies–Hypotonia–Seizures Syndrome Type 3 (MCAHS3). It identifies specific genetic mutations causing the syndrome.
TEST-3483 PITX3 Gene Anterior Segment Mesenchymal Dysgenesis (ASMD) Genetic Test This test evaluates the PITX3 gene for pathogenic variants associated with anterior segment mesenchymal dysgenesis (ASMD) and related congenital eye anomalies.	Peripheral Whole Blood (EDTA)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PITX3 gene variants", "Pathogenic mutations"] Parameters [] Preparation [] Indications ["Diagnosis of ASMD", "Family risk assessment for ASMD", "Genetic counseling for congenital eye conditions"] Measurement technique Confirm with laboratory Codes LOINC: 21634-7 ICD-10: Q13.8, Q15.0, Q13.4 Clinical summary This test evaluates the PITX3 gene for pathogenic variants associated with anterior segment mesenchymal dysgenesis (ASMD) and related congenital eye anomalies.
TEST-3593 PLCE1 Gene (Nephrotic Syndrome Type 3) Genetic Test This genetic test identifies pathogenic variants in the PLCE1 gene, which are associated with autosomal recessive nephrotic syndrome type 3.	Peripheral Whole Blood (EDTA tube)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PLCE1 gene variants", "Pathogenic mutations"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any relevant family history"] Indications ["Diagnosis of nephrotic syndrome type 3", "Carrier status determination", "Reproductive planning"] Measurement technique Confirm with laboratory Codes LOINC: 81269-6 ICD-10: N04.9 Clinical summary This genetic test identifies pathogenic variants in the PLCE1 gene, which are associated with autosomal recessive nephrotic syndrome type 3.
TEST-4941 POGZ Gene Sequencing (Mental Retardation, Autosomal Dominant Type 37) Test This test detects pathogenic variants in the POGZ gene associated with autosomal dominant mental retardation type 37 (MRD37).	Whole Blood (3-5 mL in EDTA tube) or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the POGZ gene"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist about high-dose anticoagulant use"] Indications ["Suspected diagnosis of autosomal dominant mental retardation type 37 (MRD37)", "Family history of MRD37", "Parental variant testing"] Measurement technique Confirm with laboratory Codes LOINC: 94896-4 ICD-10: F79 Clinical summary This test detects pathogenic variants in the POGZ gene associated with autosomal dominant mental retardation type 37 (MRD37).
TEST-5119 POLG Gene MNGIE Without Leukoencephalopathy Genetic Test This test evaluates the entire POLG gene for pathogenic variants associated with Mitochondrial Neurogastrointestinal Encephalopathy (MNGIE) without leukoencephalopathy.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the POLG gene", "Copy number variants in the POLG gene"] Parameters [] Preparation ["No specific fasting required.", "No specific medication or diet restrictions."] Indications ["Suspected MNGIE without leukoencephalopathy", "Family history of mitochondrial disorders", "Carrier screening", "Familial risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: E88.8 Clinical summary This test evaluates the entire POLG gene for pathogenic variants associated with Mitochondrial Neurogastrointestinal Encephalopathy (MNGIE) without leukoencephalopathy.
TEST-4023 PPARG Gene Carotid Intimal Medial Thickness Type 1 Genetic Test This genetic test evaluates variants in the PPARG gene associated with increased risk for atherosclerosis and carotid intimal-medial thickness.	Whole Blood (EDTA tube), Extracted DNA, or Finger-Prick Blood on FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PPARG gene variants", "Genetic susceptibility to atherosclerosis", "Carotid Intimal Medial Thickness (CIMT) risk"] Parameters [] Preparation ["No specific fasting required.", "Do not discontinue prescribed medications without consulting your doctor."] Indications ["Assessment of genetic predisposition to cardiovascular disease", "Risk stratification for atherosclerosis", "Family history of early-onset cardiovascular disease"] Measurement technique Confirm with laboratory Codes LOINC: 81497-9 ICD-10: Z13.6 Clinical summary This genetic test evaluates variants in the PPARG gene associated with increased risk for atherosclerosis and carotid intimal-medial thickness.
TEST-2135 PRKAR1A Gene Carney Complex Type 1 Genetic Test This test evaluates the PRKAR1A gene for pathogenic variants associated with Carney Complex Type 1.	Peripheral Whole Blood (3–5 mL in EDTA tube) or Extracted DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PRKAR1A gene", "Coverage of all exons and splice sites"] Parameters [] Preparation ["Genetic counseling session advised prior to testing", "Share complete clinical history with phlebotomist"] Indications ["Individuals with a family history of Carney Complex", "Individuals with clinical features suggestive of Carney Complex (e.g., myxomas, spotty skin pigmentation, endocrine overactivity)"] Measurement technique Confirm with laboratory Codes LOINC: 82941-0 ICD-10: E31.9 Clinical summary This test evaluates the PRKAR1A gene for pathogenic variants associated with Carney Complex Type 1.
TEST-5943 PRPS1 Gene Phosphoribosylpyrophosphate Synthetase Superactivity Genetic Test This genetic test identifies pathogenic variants in the PRPS1 gene associated with phosphoribosylpyrophosphate synthetase superactivity.	Whole Blood / Extracted DNA / FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PRPS1 gene", "Purine metabolism disorder"] Parameters [] Preparation ["Pre-test genetic counselling session required", "Pedigree chart documentation required"] Indications ["Clinical suspicion of PRPS1-related disorder", "Family history of PRPS1-related disorder", "Confirmation of biochemical findings"] Measurement technique Confirm with laboratory Codes LOINC: 81318-5 ICD-10: E79.8 Clinical summary This genetic test identifies pathogenic variants in the PRPS1 gene associated with phosphoribosylpyrophosphate synthetase superactivity.
TEST-5940 PSPH Gene Phosphoserine Phosphatase Deficiency Genetic Test This test detects pathogenic variants in the PSPH gene associated with phosphoserine phosphatase deficiency.	Whole blood (EDTA), extracted genomic DNA, or dried blood spot (FTA card)	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PSPH gene", "Copy number variations (CNV) in the PSPH gene"] Parameters [] Preparation ["Pre-test genetic counseling recommended", "Completed clinical history form required", "Three-generation pedigree chart required"] Indications ["Suspected phosphoserine phosphatase deficiency", "Family history of serine biosynthesis defects", "Neu-Laxova syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 82289-0 ICD-10: E72.8 Clinical summary This test detects pathogenic variants in the PSPH gene associated with phosphoserine phosphatase deficiency.
TEST-2165 PTCH1 Gene (Gorlin Syndrome/Basal Cell Nevus Syndrome) Genetic Test This genetic test evaluates the PTCH1 gene for mutations associated with Gorlin syndrome (Basal Cell Nevus Syndrome), a hereditary cancer predisposition syndrome.	Peripheral Whole Blood or Saliva	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PTCH1 gene mutations", "Copy Number Variations (CNVs) in PTCH1 gene"] Parameters [] Preparation ["No specific fasting required", "Inform the lab of any medications being taken"] Indications ["Individuals with clinical features suggestive of Gorlin syndrome", "Family history of Gorlin syndrome", "Pre-implantation genetic diagnosis (PGD) or prenatal diagnosis in affected families"] Measurement technique Confirm with laboratory Codes LOINC: 82901-2 ICD-10: Q87.89 Clinical summary This genetic test evaluates the PTCH1 gene for mutations associated with Gorlin syndrome (Basal Cell Nevus Syndrome), a hereditary cancer predisposition syndrome.
TEST-3076 PTCH1 Gene Sequencing (Basal Cell Nevus Syndrome) Test This test evaluates the PTCH1 gene for pathogenic variants associated with Gorlin syndrome (basal cell nevus syndrome). It utilizes Next-Generation Sequencing (NGS) with full copy...	Whole blood (4 mL EDTA), extracted DNA, or dried blood spot (FTA card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PTCH1 gene coding regions", "PTCH1 gene splice sites", "Copy Number Variations (CNVs) in PTCH1"] Parameters [] Preparation ["No specific drug avoidance is required.", "A mandatory pre-test genetic counselling session will be conducted via teleconsultation."] Indications ["Clinical suspicion of Gorlin syndrome (basal cell nevus syndrome)", "Family history of Gorlin syndrome", "Multiple basal cell carcinomas, especially early onset", "Presence of jaw keratocysts, palmar/plantar pits, or other associated features"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Q87.89 Clinical summary This test evaluates the PTCH1 gene for pathogenic variants associated with Gorlin syndrome (basal cell nevus syndrome). It utilizes Next-Generation Sequencing (NGS) with full copy number variation (CNV) analysis.

Category overview

Gene Sequencing: overview

Achieving a definitive diagnosis for a complex or rare genetic disorder often requires reading the entire genetic code of specific genes to find elusive, hidden errors. As a cornerstone of our advanced Genetics services, Gene Sequencing expansively scans the targeted regions of your genome to uncover rare or novel mutations that standard tests miss. Utilizing state-of-the-art sequencing technology, this comprehensive molecular profiling delivers the critical data necessary to safely guide your healthcare provider in tailoring highly personalized medical management and targeted therapeutic interventions. Trusted for molecular excellence among premier diagnostic labs in the UAE, DNA Labs ensures absolute patient confidentiality, exceptional analytical precision, and remarkably fast reporting. Find the clear, definitive answers you need—schedule your gene sequencing testing in UAE, coordinate a seamless clinical sample transfer, or consult our expert medical genetics professionals today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.